Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CAZALY RESOURCES LIMITED Capital/Financing Update 2019

Mar 21, 2019

64609_rns_2019-03-21_990a4273-19d1-43f3-867e-a5c0b69abaae.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

==> picture [169 x 91] intentionally omitted <==

22 March 2019

SECONDARY TRADING NOTICE PURSUANT TO SECTION 708A(5) OF THE CORPORATIONS ACT 2001 (“Act”)

On 22 March 2019, Cazaly Resources Limited (“ the Company ”) issued a total of 29,000,000 fully paid ordinary shares (‘Shares’) in the Company to sophisticated and professional investors under a placement announced on 18 March 2019.

The Act restricts the on-sale of securities issued without disclosure, unless the sale is exempt under section 708 or 708A of the Act. By giving this notice, the on sale of the Shares noted above will fall within the exemption in section 708A(5) of the Act.

The Company hereby notifies ASX under paragraph 708A(5)(e) of the Act that, as at 22 March 2019:

  • a) The Company issued a total of 29,000,000 Shares without disclosure to investors under Part 6D.2 of the Act;

  • b) The Company has complied with the provisions of Chapter 2M of the Act as they apply to the Company, and section 674 of the Act; and

  • c) There is no information:

  • a. That has been excluded from a continuous disclosure notice in accordance with the ASX Listing Rules; and

  • b. That investors and their professional advisers would reasonably require for the purpose of making an informed assessment of:

    • i. The assets and liabilities, financial position and performance, profits and losses and prospects of the Company; or

    • ii. The rights and liabilities attaching to the Shares.

An Appendix 3B is attached in respect of the issue of the total number of Shares.

Yours faithfully

Mike Robbins Company Secretary

Level 2, 38 Richardson Street West Perth Western Australia, 6005. PO Box 396, West Perth, Western Australia, 6872 Phone: +61 8 9322 6283 Fax: +61 8 9322 6398 email: [email protected] ACN 101 049334 www.cazalyresources.com.au

Rule 2.7, 3.10.3, 3.10.4, 3.10.5

Appendix 3B

New issue announcement, application for quotation of additional securities and agreement

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12, 04/03/13

Name of entity

Cazaly Resources Limited

ABN

23 101 049 334

We (the entity) give ASX the following information.

Part 1 - All issues

You must complete the relevant sections (attach sheets if there is not enough space).

  • 1 +Class of +securities issued or to be 1. Fully paid ordinary shares issued 2. Unquoted options

  • 2 Number of[+] securities issued or to 1. 29,000,000 be issued (if known) or maximum 2. 14,500,000 number which may be issued

  • 3 Principal terms of the[+] securities (e.g. if options, exercise price and expiry date; if partly paid 1. Fully paid ordinary shares +securities, the amount outstanding 2. Unquoted options exercisable at $0.05 on or and due dates for payment; if before 31 March 2021 +convertible securities, the conversion price and dates for conversion)

  • See chapter 19 for defined terms.

Appendix 3B Page 2

04/03/2013

4
Do the+securities rank equally in
all respects from the+issue date
with an existing+class of quoted
+securities?
If the additional+securities do not
rank equally, please state:
• the date from which they do
• the extent to
which they
participate
for
the
next
dividend, (in the case of a trust,
distribution) or interest payment
• the extent to which they do not
rank equally, other than in
relation to the next dividend,
distribution or interest payment
5
Issue price or consideration
6
Purpose of the issue
(If issued as consideration for the
acquisition
of
assets,
clearly
identify those assets)
6a
Is the entity an+eligible entity that
has
obtained
security
holder
approval under rule 7.1A?
If Yes, complete sections 6b – 6h_in_
relation to the+securities the
subject of this Appendix 3B, and
comply with section 6i
6b
The date the security holder
resolution under rule 7.1A was
passed
6c
Number
of
+securities
issued
without security holder approval
under rule 7.1
6d
Number of+securities issued with
security holder approval under rule
7.1A
6e
Number of+securities issued with
security holder approval under rule
7.3, or another specific security
holder approval (specify date of
meeting)
1.
Yes – rank equally with existing fully paid
ordinary shares.
2.
No – shares issued upon exercise of options will
rank equally with existing fully paid ordinary
shares
1. $0.025
2. Nil
Placement – Funds raised will be used to update various
sections and costings of the Definitive Feasibility Study
on the Parker Range Iron Ore project, planned
exploration work on other projects in Namibia and
Australia and for working capital requirements.
Yes
23 November 2018
8,415,799 fully paid ordinary shares
14,500,000 unquoted options exercisable at $0.05
on or before 31 March 2021
20,584,201 fully paid ordinary shares
Nil
  • See chapter 19 for defined terms.

Appendix 3B Page 3

04/03/2013

6f
Number of+securities issued under
an exception in rule 7.2
6g
If+securities issued under rule
7.1A, was issue price at least 75%
of 15 day VWAP as calculated
under rule 7.1A.3? Include the
+issue date and both values.
Include the source of the VWAP
calculation.
6h
If+securities were issued under rule
7.1A for non-cash consideration,
state date on which valuation of
consideration was released to ASX
Market Announcements
6i
Calculate the entity’s remaining
issue capacity under rule 7.1 and
rule 7.1A – complete Annexure 1
and
release
to
ASX
Market
Announcements
7
+Issue dates
Note: The issue date may be prescribed by ASX
(refer to the definition of issue date in rule 19.12).
For example, the issue date for a pro rata
entitlement issue must comply with the applicable
timetable in Appendix 7A.
Cross reference: item 33 of Appendix 3B.
8
Number and+class of all+securities
quoted on ASX (_including_the
+securities
in
section
2
if
applicable)
9
Number and+class of all+securities
not quoted on ASX (_including_the
securities in section 2 if applicable)
Nil Nil Nil

Yes
Issue price $0.025
15 day VWAP = $0.0305 (75% = $0.02287)
Source – Advanced Share Registry
N/A
11,639,191
22 March 2019
Number +Class
261,819,058 Fully paid ordinary shares
Number +Class
1,450,000
2,500,000
2,500,000
8,750,000
7,300,000
29,920,000
$0.18 Options exercisable on or
before 22 August 2019
$0.144 Options exercisable on or
before 22 August 2019
$0.216 Options exercisable on or
before 22 August 2020
$0.06 Options exercisable on or
before 26 November 2020
$0.06 Options exercisable on or
before 31 December 2019
$0.02745 Options exercisable on or
before 31December 2021
  • See chapter 19 for defined terms.

Appendix 3B Page 4

04/03/2013

14,500,000
$0.05 Options exercisable on or
before 31 March 2021
10
Dividend policy (in the case of a
trust, distribution policy) on the
increased capital (interests)
N/A
Part 2 - Bonus issue or pro rata issue
11
Is security holder approval required?
12
Is the issue renounceable or non-
renounceable?
13
Ratio in which the+securities will be
offered
14
+Class of+securities to which the
offer relates
15
+Record
date
to
determine
entitlements
16
Will holdings on different registers
(or subregisters) be aggregated for
calculating entitlements?
17
Policy for deciding entitlements in
relation to fractions
18
Names of countries in which the
entity has+security holders who will
not be sent new issue documents
Note: Security holders must be told how their
entitlements are to be dealt with.
Cross reference: rule 7.7.
19
Closing
date
for
receipt
of
acceptances or renunciations
20
Names of any underwriters
21
Amount of any underwriting fee or
commission
22
Names of any brokers to the issue
23
Fee or commission payable to the
broker to the issue
14,500,000 $0.05 Options exercisable on or
before 31 March 2021
N/A
  • See chapter 19 for defined terms.

Appendix 3B Page 5

04/03/2013

24 Amount of any handling fee payable
to brokers who lodge acceptances or
renunciations on behalf of+security
holders
25 If the issue is contingent on+security
holders’ approval, the date of the
meeting
26 Date entitlement and acceptance
form and prospectus or Product
Disclosure Statement will be sent to
persons entitled
27 If the entity has issued options, and
the terms entitle option holders to
participate on exercise, the date on
which notices will be sent to option
holders
28 Date rights trading will begin (if
applicable)
29 Date rights trading will end (if
applicable)
30 How do+security holders sell their
entitlements_in full_through a
broker?
31 How do+security holders sell_part_of
their entitlements through a broker
and accept for the balance?
32 How do+security holders dispose of
their entitlements (except by sale
through a broker)?
33 +Despatch date

Part 3 - Quotation of securities

You need only complete this section if you are applying for quotation of securities

  • 34 Type of securities

  • ( tick one )

  • (a) [Securities described in Part 1 ]

  • (b)[All other securities ]

    • Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities

Entities that have ticked box 34(a)

Additional securities forming a new class of securities

  • See chapter 19 for defined terms.

Appendix 3B Page 6

04/03/2013

Tick to indicate you are providing the information or documents

35 If the[+] securities are[+] equity securities, the names of the 20 largest holders of the additional[+] securities, and the number and percentage of additional[+] securities held by those holders

36 If the[+] securities are[+] equity securities, a distribution schedule of the additional +securities setting out the number of holders in the categories 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001 and over 37 A copy of any trust deed for the additional[+] securities

Entities that have ticked box 34(b)

38
Number of securities for which
+quotation is sought
39
Class of
+securities for which
quotation is sought
40
Do the+securities rank equally in all
respects from the date of allotment
with an existing+class of quoted
+securities?
If the additional securities do not
rank equally, please state:
• the date from which they do
• the
extent
to
which
they
participate for the next dividend,
(in
the
case
of
a
trust,
distribution) or interest payment
• the extent to which they do not
rank equally, other than in
relation to the next dividend,
distribution or interest payment
41
Reason for request for quotation now
Example: In the case of restricted securities, end of
restriction period
(if issued upon conversion of another
security, clearly identify that other
security)
42
Number and+class of all+securities
quoted on ASX (_including_the
securities in clause 38)
Number +Class
  • See chapter 19 for defined terms.

Appendix 3B Page 7

04/03/2013

Quotation agreement

  • 1 +Quotation of our additional +securities is in ASX’s absolute discretion. ASX may quote the +securities on any conditions it decides.

  • 2 We warrant the following to ASX.

  • The issue of the[+] securities to be quoted complies with the law and is not for an illegal purpose.

  • There is no reason why those[+] securities should not be granted[+] quotation.

  • An offer of the[+] securities for sale within 12 months after their issue will not require disclosure under section 707(3) or section 1012C(6) of the Corporations Act.

Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty

  • Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any[+] securities to be quoted and that no-one has any right to return any[+] securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the[+] securities be quoted.

  • If we are a trust, we warrant that no person has the right to return the[+] securities to be quoted under section 1019B of the Corporations Act at the time that we request that the +securities be quoted.

  • 3 We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.

  • 4 We give ASX the information and documents required by this form. If any information or document not available now, will give it to ASX before[+] quotation of the[+] securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.

Sign here: ............................................................ Date: 22 March 2019 (Company Secretary)

Print name: Mike Robbins

== == == == ==

Appendix 3B – Annexure 1

Calculation of placement capacity under rule 7.1 and rule 7.1A for +eligible entities

Introduced 01/08/12 Amended 04/03/13

Part 1

Rule 7.1 – Issues exceeding 15% of capital

Step 1: Calculate “A”, the base figure from which the placement capacity is calculated

==> picture [415 x 380] intentionally omitted <==

----- Start of picture text -----

Insert number of fully paid ordinary 195,931,002
securities on issue 12 months before date
of issue or agreement to issue
Add the following:
• Number of fully paid ordinary securities 6,000,000 shares (Kaoko Kobalt purchase)
issued in that 12 month period under an
28,435,597 shares (placement)
exception in rule 7.2
• Number of fully paid ordinary securities
issued in that 12 month period with
shareholder approval
• Number of partly paid ordinary
securities that became fully paid in that
12 month period
Note:
• Include only ordinary securities here –
other classes of equity securities cannot
be added
• Include here (if applicable) the securities
the subject of the Appendix 3B to which
this form is annexed
• It may be useful to set out issues of
securities on different dates as separate
line items
Subtract the number of fully paid ordinary 0
securities cancelled during that 12 month
period
“A” 230,366,599
----- End of picture text -----

  • See chapter 19 for defined terms.

Appendix 3B Page 9

04/03/2013

Step 2: Calculate 15% of “A”

Step 2: Calculate 15% of “A”
“B” 0.15
[Note: this value cannot be changed]
Multiply“A” by 0.15 34,554,990
Step 3: Calculate “C”, the amount of placement capacity under rule 7.1
that has already been used
Insertnumber of equity securities issued or
agreed to be issued in that 12 month period
_not counting_those issued:
• Under an exception in rule 7.2 8,415,799 shares (placement)
• Under rule 7.1A 14,500,000 unlisted options (placement)
• With security holder approval under rule
7.1 or rule 7.4
Note:
• This applies to equity securities, unless
specifically excluded – not just ordinary
securities
• Include here (if applicable ) the
securities the subject of the Appendix
3B to which this form is annexed
• It may be useful to set out issues of
securities on different dates as separate
line items
  • Include here (if applicable ) the securities the subject of the Appendix 3B to which this form is annexed

  • • It may be useful to set out issues of securities on different dates as separate line items

  • “C” 22,915,799

Step 4: Subtract “C” from [“A” x “B”] to calculate remaining placement capacity under rule 7.1

placement capacity under rule 7.1
“A” x 0.15 34,554,990
Note: number must be same as shown in
Step 2
Subtract“C” 22,915,799
Note: number must be same as shown in
Step 3
Total[“A” x 0.15] – “C” 11,639,191
[Note: this is the remaining placement
capacity under rule 7.1]
  • See chapter 19 for defined terms.

Appendix 3B Page 10

04/03/2013

Part 2

Rule 7.1A – Additional placement capacity for eligible entities

Step 1: Calculate “A”, the base figure from which the placement capacity is calculated

“A” Note: number must be same as shown in Step 1 230,366,599 of Part 1 Step 2: Calculate 10% of “A” “D” 23,036,660 Note: this value cannot be changed Multiply “A” by 0.10

Step 3: Calculate “E”, the amount of placement capacity under rule 7.1A that has already been used

has already been used
Insertnumber of equity securities issued or 2,452,459 shares (Note deed fees)
agreed to be issued in that 12 month period
under rule 7.1A
20,584,201 shares (placement)
Notes:

This applies to equity securities – not just
ordinary securities

Include here – if applicable – the securities
the subject of the Appendix 3B to which this
form is annexed

Do not include equity securities issued under
rule 7.1 (they must be dealt with in Part 1),
or for which specific security holder approval
has been obtained

It may be useful to set out issues of
securities on different dates as separate line
items
“E” 23,036,660
Step 4: Subtract “E” from [“A” x “D”] to calculate remaining placement capacity
under rule 7.1A
“A” x 0.10 23,036,660
Note: number must be same as shown in Step 2
Subtract“E” 23,036,660
Note: number must be same as shown in Step 3
“A” x 0.10 23,036,660
Note: number must be same as shown in Step 2
Subtract“E” 23,036,660
Note: number must be same as shown in Step 3
Total[“A” x 0.10] – “E” Nil
Note: this is the remaining placement capacity under rule 7.1A
  • See chapter 19 for defined terms.

Appendix 3B Page 11

04/03/2013